← FDA Drug Approvals (Drugs@FDA)

VALBENAZINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SANDOZ INC · Approved 2022-12-12

Drug application

FDA Application #
ANDA215962
Application type
Abbreviated New Drug Application (Generic)
Brand name
VALBENAZINE
Generic name
Valbenazine
Active ingredients
VALBENAZINE
Dosage form
CAPSULE
Route
ORAL
Marketing status
None (Tentative Approval)
Sponsor
SANDOZ INC
First approval
2022-12-12

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown